Ivermectin
Ivergelan, Ivermectin Stada, Scabioral, Soolantra · ATC code P02CF01
Also known as: İvermektin · Brand names: Ivergelan, Ivermectin Stada, Scabioral, Soolantra, Driponin, Iveraxiro, Ivermectin Al, Ivermectin Aristo, Ivermectin Biomo, Ivermectin Glenmark, Ivermectin Orifarm, Ivermectin Orion, Ivermectin Pädia, Ivermectin Ratiopharm, Armec …
- Key facts
- Active substance
- Ivermectin
- Drug class
- Avermectin
- ATC code
- P02CF01
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-10-27
Key facts
Ivermectin (Stromectol) is an anthelmintic indicated, per the US prescribing information, for intestinal strongyloidiasis and onchocerciasis.
What it is used for
- Intestinal (nondisseminated) strongyloidiasis due to Strongyloides stercoralis
- Onchocerciasis due to Onchocerca volvulus (no activity against adult parasites)
Dosing
- Strongyloidiasis: single oral dose of approximately 200 mcg/kg body weight; tablet number per weight table
- Strongyloidiasis: additional doses generally not necessary; follow-up stool examinations to verify eradication
- Onchocerciasis: single oral dose of approximately 150 mcg/kg; retreatment of individual patients may be considered at intervals as short as 3 months
- Take on an empty stomach with water
- Safety in pediatric patients under 15 kg not established
Contraindications
- Hypersensitivity to any component of the product
Important warnings
- Onchocerciasis: Mazzotti reaction (cutaneous and systemic) and ophthalmological reactions from dying microfilariae
- Neurotoxicity including altered consciousness up to coma, confusion and death has been reported
- Patients with hyperreactive onchodermatitis (sowda) may be more likely to have severe reactions
Side effects
- Strongyloidiasis: dizziness, pruritus, nausea, diarrhea, fatigue, abdominal pain, somnolence, tremor, rash
- Laboratory: ALT/AST elevation, decreased leukocyte count
- Onchocerciasis: Mazzotti-type reactions and postural hypotension
Interactions
- Warfarin: elevated INR rarely reported
Pregnancy and breastfeeding
- Should not be used during pregnancy since safety has not been established
- Excreted in human milk in low concentrations; treat nursing mothers only if the benefit outweighs the risk
Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
Austria
- IvergelanG.L. Pharma Gmbh · 1 register entry
- Ivermectin StadaStada Arzneimittel Gmbh · 1 register entry
- ScabioralInfectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim · 1 register entry
- SoolantraGalderma International · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Germany
- DriponinPädia Gmbh, De, Heppenheim · 1 register entry
- IveraxiroMedical Valley Invest Ab · 1 register entry
- Ivermectin AlAliud Pharma Gmbh · 2 register entries
- Ivermectin AristoAristo Pharma Gmbh (Art 57) · 1 register entry
- Ivermectin BiomoBiomo Pharma Gmbh · 1 register entry
- Ivermectin GlenmarkGlenmark Arzneimittel Gmbh · 1 register entry
- Ivermectin OrifarmOrifarm Healthcare A/S · 1 register entry
- Ivermectin OrionOrion Corporation · 1 register entry
- Ivermectin PädiaPädia Gmbh, De, Heppenheim · 1 register entry
- Ivermectin RatiopharmRatiopharm Gmbh · 1 register entry
- Ivermectin StadaStadapharm Gmbh · 1 register entry
- ScabioralInfectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim · 1 register entry
Show all 13 brand names
- SoolantraGalderma Laboratorium Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Turkey
- ArmecALİ RAİF İLAÇ SAN. A.Ş. · 7 register entries
- ErmetinWORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş. · 5 register entries
- IveraxiroEXELTIS İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
- İvercidFARMA-TEK İLAÇ SAN. VE TİC. A.Ş. · 6 register entries
- ZiverHUMANİS SAĞLIK A.Ş. · 7 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
USA
- SoolantraGalderma Laboratories, L.P. · 1 register entry
- StromectolMerck Sharp & Dohme LLC · 1 register entry
Source: U.S. FDA – Drug labels (openFDA/DailyMed), as of 2026-10-28
Brand names in 25 more European countries
- Belgium
- Cesora, Ivermectin Eg, Ivermectin Substipharm, Soolantra
- Bulgaria
- Ивермектин, Скабал, Соолантра, Хювемек
- Cyprus
- Scaball, Soolantra
- Czechia
- Ivermektin Aristo, Loutol, Soolantra
- Denmark
- Ivermectin Medical Valley, Ivermectin Newbury, Ivermectin Orifarm, Ivermectin Orion, Ivermectin Stada Ag, Scatol, Soolantra
- Estonia
- Ivermectin Orion, Soolantra
- Finland
- Ivermectin Glenmark, Ivermectin Medical Valley, Ivermectin Orifarm, Ivermectin Orion, Ivermectin Stada, Ivermectine Ratiopharm, Scatol, Soolantra
- France
- Bibovel, Cesora, Ivermectine Arrow Lab, Ivermectine Biogaran, Ivermectine Cristers, Ivermectine Eg, Ivermectine Liconsa, Ivermectine Pharmaki Generics, Ivermectine Pierre Fabre, Ivermectine Sandoz, Ivermectine Substipharm, Ivermectine Teva, Ivermectine Viatris, Ivermectine Zentiva, Mectizan, Soolantra, Stromectol, Vona
- Greece
- Scaball, Soolantra
- Hungary
- Soolantra
- Iceland
- Ivermcetin Stada, Ivermectin Medical Valley, Ivermectin Stada, Soolantra
- Ireland
- Iverscab, Soolantra
- Italy
- Efacti, Ivercare, Ivermectina Difa, Ivermectina Giuliani, Iverscab, Ivesk, Scaver
- Latvia
- Ivermectin Orion, Ivermectine Orion, Soolantra
- Lithuania
- Ivermectin Orion, Soolantra
- Luxembourg
- Ivermectin Eg, Ivermectin Substipharm, Soolantra
- Malta
- Soolantra
- Netherlands
- Ivergalen, Ivermectin Substipharm, Ivermectine Aristo, Ivermectine Cf, Ivermectine Glenmark, Ivermectine Orion, Ivermectine Teva, Ivermectine Xiromed, Iverscab, Posela, Soolantra, Stromectol
- Norway
- Ivermectin Glenmark, Ivermectin Medical Valley, Ivermectin Newbury, Ivermectin Orifarm Healthcare, Ivermectin Orion, Ivermectin Stada Arzneimittel Ag, Scatol, Soolantra
- Poland
- Ivermectin Medical Valley, Ivermectin Orion, Ivermectin Stada, Posela, Scavertin, Soolantra, Vesarco, Yverfast
- Portugal
- Ivergalen, Ivermectina Cantabria, Ivertopic, Soolantra
- Romania
- Soolantra
- Slovakia
- Ivermectin Exeltis, Soolantra
- Spain
- Ivercare, Ivergalen, Ivermectina Aristo, Ivermectina Stada, Ivermectina Teva, Ivertilene, Soolantra, Zulima
- Sweden
- Cesora, Efrinter, Ivermectin Aristo, Ivermectin Medical Valley, Ivermectin Newbury, Ivermectin Orifarm, Ivermectin Orion, Ivermectin Stada, Scatol, Soolantra, Yverfast
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. STROMECTOL (Merck Sharp & Dohme LLC) – Prescribing Information, 2024-09-20. DailyMed (NLM), 2026-10-27. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=681888c9-af79-4b7d-ae80-c3f4f6f1effd
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
- U.S. FDA – Drug labels (openFDA/DailyMed), 2026-10-28. https://dailymed.nlm.nih.gov/dailymed/
- Wikidata (CC0): ATC P02CF.
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.